Bio-Path Holdings, Inc. Profile Avatar - Palmy Investing

Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P…

Biotechnology
US, Bellaire [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of BPTH's Analysis
CIK: 1133818 CUSIP: 09057N300 ISIN: US09057N3008 LEI: - UEI: -
Secondary Listings
BPTH has no secondary listings inside our databases.